ES2189372T3 - Uso de derivados de cromanos y/o cromenos para prevenir reacciones oxidativas inducidas por radicales libres. - Google Patents

Uso de derivados de cromanos y/o cromenos para prevenir reacciones oxidativas inducidas por radicales libres.

Info

Publication number
ES2189372T3
ES2189372T3 ES99500138T ES99500138T ES2189372T3 ES 2189372 T3 ES2189372 T3 ES 2189372T3 ES 99500138 T ES99500138 T ES 99500138T ES 99500138 T ES99500138 T ES 99500138T ES 2189372 T3 ES2189372 T3 ES 2189372T3
Authority
ES
Spain
Prior art keywords
chrome
free radicals
derivatives
sub
prevent oxidative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99500138T
Other languages
English (en)
Inventor
Lambiez Fernando Pons
Gonzalez Raquel Delgado
Duena Antonio Parente
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipotec SA
Original Assignee
Lipotec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec SA filed Critical Lipotec SA
Application granted granted Critical
Publication of ES2189372T3 publication Critical patent/ES2189372T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Un procedimiento para reducir químicamente las reacciones de oxidación o las inducidas por radicales libres. Comprende la administración tópica u oral de una cantidad eficaz de un compuesto de fórmula general A o B, en las que R2 son iguales o diferentes y se seleccionan independientemente del grupo constituido por OH-, CH{sub,3}-, CF{sub,3}CH{sub,2}O- y CH{sub,3}O-.
ES99500138T 1998-09-16 1999-09-10 Uso de derivados de cromanos y/o cromenos para prevenir reacciones oxidativas inducidas por radicales libres. Expired - Lifetime ES2189372T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009801947A ES2154560B1 (es) 1998-09-16 1998-09-16 Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.

Publications (1)

Publication Number Publication Date
ES2189372T3 true ES2189372T3 (es) 2003-07-01

Family

ID=8305178

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009801947A Expired - Lifetime ES2154560B1 (es) 1998-09-16 1998-09-16 Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.
ES99500138T Expired - Lifetime ES2189372T3 (es) 1998-09-16 1999-09-10 Uso de derivados de cromanos y/o cromenos para prevenir reacciones oxidativas inducidas por radicales libres.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES009801947A Expired - Lifetime ES2154560B1 (es) 1998-09-16 1998-09-16 Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.

Country Status (7)

Country Link
EP (1) EP1002533B1 (es)
JP (1) JP4723705B2 (es)
AT (1) ATE228836T1 (es)
DE (1) DE69904282T2 (es)
DK (1) DK1002533T3 (es)
ES (2) ES2154560B1 (es)
PT (1) PT1002533E (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19941595A1 (de) * 1999-09-01 2001-03-08 Basf Ag Verwendung von anellierten Benzolderivaten als Antioxidans oder Radikalfänger in kosmetischen Zubereitungen
AU2001242502A1 (en) * 2000-03-31 2001-10-15 Henkel Kommanditgesellschaft Auf Aktien Use of protease inhibitors in cosmetics and pharmacy
FR2808189B1 (fr) 2000-04-28 2004-03-05 Oreal Lipochroman-6 comme inhibiteur de no-synthase et utilisations
DE10259014A1 (de) 2002-12-16 2004-06-24 Henkel Kgaa Antioxidans-Kombinationen mit6,7-disubstituierten 2,2-Dialkylchromanen oder-chromenen
DE102004039729A1 (de) * 2004-08-16 2006-03-09 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (-)2-Hydroxymethyl-2-Methyl-6-hydroxychromen bzw. einen Extrakt aus Pilzen der Art Daedalea quercina, (-)2-Hydroxymethyl-2-Methyl-6-hydrocychromen enthaltend
DE102006062501A1 (de) 2006-12-28 2008-07-03 Henkel Kgaa Kosmetische und dermatologische Öl-in-Wasser-Emulsionen mit selbstkonservierenden Eigenschaften
ES2310142B1 (es) 2007-06-15 2009-12-04 Lipotec S.A Compuestos reguladores de la pigmentacion.
EP2113242A1 (en) * 2008-05-02 2009-11-04 Pangaea Laboratories Limited Antioxidant for use in cosmetic, medicated and pharmaceutical preparations
FR2934490B1 (fr) * 2008-08-01 2010-09-17 Lvmh Rech Utilisation dans une composition cosmetique du lipochroman-6 pour ameliorer l'eclat du teint de la peau, notamment du visage
DE102009017612A1 (de) * 2009-04-20 2010-10-21 Henkel Ag & Co. Kgaa Hautbehandlungsmittel gegen Hautalterung I
DE102009026414A1 (de) 2009-05-22 2010-11-25 Henkel Ag & Co. Kgaa Hautbehandlung zur Porenverfeinerung
DE102009027024A1 (de) 2009-06-18 2010-12-23 Henkel Ag & Co. Kgaa Antifalten-Kosmetikum mit Antioxidantien
DE102009027105A1 (de) * 2009-06-23 2010-12-30 Henkel Ag & Co. Kgaa Sonnenschutzzusammensetzungen mit verbessertem antioxidativen Potenzial
DE102009027199A1 (de) * 2009-06-25 2010-12-30 Henkel Ag & Co. Kgaa UV-Schutz-Kosmetikum
DE102010062915A1 (de) * 2010-12-13 2012-06-14 Henkel Ag & Co. Kgaa Synergistische Wirkstoffkombination zum Schutz der Haut vor IR-Strahlung
DE102011079256A1 (de) * 2011-07-15 2013-01-17 Henkel Ag & Co. Kgaa Sonnenschutzzusammensetzungen mit verbessertem antioxidativen Potenzial zum Schutz der Haut vor IR-Strahlung
JP2017088496A (ja) * 2014-03-19 2017-05-25 三菱化学株式会社 皮膚外用剤
EP3370689B1 (en) * 2015-11-02 2023-10-04 Lubrizol Advanced Materials, Inc. Composition for protecting the skin against the effects of pollution and use thereof
DE102016225095B4 (de) 2016-12-15 2024-08-29 Henkel Ag & Co. Kgaa "Kosmetische Gesichtspflegeformulierungen zur Stimulierung der körpereigenen Abwehr gegen freie Radikale"
KR101784331B1 (ko) * 2017-02-27 2017-10-12 주식회사 아제라바이오텍 아쿠아포린-3의 발현을 증가시키는 6,7-디메톡시-2,2-디메틸-2h-크로멘 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03261705A (ja) * 1990-03-09 1991-11-21 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
FR2695387B1 (fr) * 1992-09-09 1994-10-21 Adir Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ES2072223B1 (es) * 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
KR100381449B1 (ko) * 1994-10-14 2003-07-18 더 리포좀 컴퍼니, 인코퍼레이티드 에테르지질리포좀과이들의제약학적용도
US5643943A (en) * 1994-12-23 1997-07-01 Alcon Laboratories, Inc. Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis
EP0869773B1 (en) * 1995-12-15 2004-03-24 National Research Council Of Canada Archaeosomes, archaeosomes containing coenzyme q 10, and other types of liposomes containing coenzyme q 10 as adjuvants and as delivery vehicles
WO1999037294A2 (en) * 1998-01-26 1999-07-29 Mitokor Mitochondria protecting agents for treating mitochondria associated diseases

Also Published As

Publication number Publication date
DK1002533T3 (da) 2003-03-17
JP4723705B2 (ja) 2011-07-13
EP1002533B1 (en) 2002-12-04
DE69904282T2 (de) 2003-11-06
ES2154560A1 (es) 2001-04-01
ES2154560B1 (es) 2001-12-01
EP1002533A1 (en) 2000-05-24
DE69904282D1 (de) 2003-01-16
ATE228836T1 (de) 2002-12-15
PT1002533E (pt) 2003-04-30
JP2000095684A (ja) 2000-04-04

Similar Documents

Publication Publication Date Title
ES2189372T3 (es) Uso de derivados de cromanos y/o cromenos para prevenir reacciones oxidativas inducidas por radicales libres.
AR035482A1 (es) Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos
DE69942306D1 (de) Abkömmlinge von glp-1 analogen
PT1193270E (pt) Pirrolobenzodiazepinas
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
ES2078905T3 (es) Nuevos compuestos heterociclicos condensados y su utilizacion para medicamentos.
ES2141183T3 (es) Utilizacion de disolventes de hidrocarburos halogenados.
NO20005835L (no) Anvendelse av trisykliske, antidepressive midler for lokal analgesi
PT946507E (pt) Compostos de pirrolilo substituidos para o tratamento da inflamacao
PT663912E (pt) Compostos de eter heterociclico que aumentam a funcao cognitiva
DK0435443T3 (da) Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion
NO20014756D0 (no) C(10)-heterosubstituerte acetattaksaner som antitmormidler
OA09770A (fr) "Dérivés de benzèneacétamide inhibiteurs du VIH".
NO302124B1 (no) Vandig sammensetning for bruk som et brönnbetjeningsfluid
ES2165029T3 (es) Hidrofluoruros de amina y su utilizacion como agentes para la higiene bucal.
ES2181927T3 (es) Derivados de 1-metilcarbapenem.
CY1105411T1 (el) Νεα παραγωγα πλευρομουτιλινης
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
DE50101861D1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
ATE132749T1 (de) Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
NO965233L (no) Deacetoksytaksolderivater
ES2136799T3 (es) Benzotiofenos de glucopiranosido.
FI924171L (fi) Heteropolycykliska biocida foereningar, deras syntes och mellanprodukter, sammansaettningar som innehaoller dem och deras anvaendning i medicin
ATE250610T1 (de) Kaliumkanal-blockierende mittel
DE50102041D1 (de) 2-hydroxy-5-amino-biphenyl-derivate sowie diese verbindungen enthaltende oxidationshaarfärbemittel